Search
for
Sort by
Research 571–600 of 1000+
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- Response of alopecia areata of the beard to oral tofacitinib
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Incipient Diabetes Mellitus and Nascent Thyroid Disease Presenting as Beard Alopecia Areata: Case Report and Treatment Review of Alopecia Areata of the Beard
- TREMendous Macrophages Inhibit Hair Growth
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Dermatologic Adverse Events from Cancer Treatments
- 1322 Molecular profiling of frontal fibrosing alopecia (FFA) reveals TH1 and JAK-STAT up-regulation with no suppression of hair keratins
- Practice and Educational Gaps in Dermatology
- Current and future pharmacotherapy for alopecia areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Mechanism of PPARα agonist in alopecia areata
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
- Alopecia universalis treated with simvastatin/ezetimibe, minoxidil, and prednisolone in a 6‐year‐old girl
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies